Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Polly A. MurphyIndependent Director | 6,10k | 25,45k | Kauf | 4,17 | 92,15k | 7,09% |
| 2026-03-11 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | 60,00k | 74,40k | Derivative Exercise and Retained Stock | 1,24 | 823,58k | 7,86% |
| 2026-01-31 | Dr. Maria Arantxa HorgaChief Medical Officer | 35,21k | 0,00 | Derivative Exercise and Retained Stock | - | 96,09k | 57,84% |
| 2026-01-31 | Dr. Maria Arantxa HorgaChief Medical Officer | -16,07k | 68,15k | Derivative Exercise and Sale | 4,24 | 96,09k | - |
| 2026-01-31 | Mr. John F. VavrickaChief Commercial Officer | 30,51k | 0,00 | Derivative Exercise and Retained Stock | - | 165,10k | 22,67% |
| 2026-01-31 | Mr. John F. VavrickaChief Commercial Officer | -11,57k | 49,06k | Derivative Exercise and Sale | 4,24 | 165,10k | - |
| 2026-01-31 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | 38,76k | 0,00 | Derivative Exercise and Retained Stock | - | 763,58k | 5,35% |
| 2026-01-31 | Ms. Andrea J. CorcoranCFO, Exec. VP of Legal & Secretary | -16,10k | 68,28k | Derivative Exercise and Sale | 4,24 | 763,58k | - |
| 2026-01-31 | Dr. Janet M. J. HammondChief Development Officer | 43,91k | 0,00 | Derivative Exercise and Retained Stock | - | 127,67k | 52,43% |
| 2026-01-31 | Dr. Janet M. J. HammondChief Development Officer | -14,14k | 59,94k | Derivative Exercise and Sale | 4,24 | 127,67k | - |
| 2026-01-31 | Dr. Jean-Pierre SommadossiFounder, Chairman, CEO & President | 466,89k | 372,00k | Derivative Exercise and Retained Stock | 1,24 | 6,63M | 7,57% |
| 2026-01-31 | Dr. Jean-Pierre SommadossiFounder, Chairman, CEO & President | -106,09k | 449,83k | Derivative Exercise and Sale | 4,24 | 6,63M | - |
| 2026-01-31 | Mr. Wayne FosterExec. VP of Finance & CAO | 29,20k | 0,00 | Derivative Exercise and Retained Stock | - | 79,33k | 58,25% |
| 2026-01-31 | Mr. Wayne FosterExec. VP of Finance & CAO | -12,13k | 51,44k | Derivative Exercise and Sale | 4,24 | 79,33k | - |
| 2025-06-20 | Mr. Bruno LucidiIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 112,75k | 35,60% |
| 2025-06-20 | Dr. Bruce W. PolskyIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 95,21k | 45,12% |
| 2025-06-20 | Dr. Polly A. MurphyIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 86,05k | 52,44% |
| 2025-06-20 | Dr. Jerome M. AdamsIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 62,75k | 89,29% |
| 2025-06-20 | Mr. Franklin M. BergerLead Independent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 506,50k | 6,21% |
| 2025-06-20 | Ms. Barbara G. DuncanIndependent Director | 29,60k | 0,00 | Derivative Exercise and Retained Stock | - | 62,75k | 89,29% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
